Find a trial at the Pfizer Clinical Research Unit
2 trials found
Recruiting
A6791042
A6791042
A medical device containing 104 mg MPA (medroxyprogesterone acetate) in 0.65 mL suspension for injection and indicated for long-term female contraception via SC injection into the anterior thigh or abdomen every 13 weeks.
In this study the medication will be administrated subcutaneously (under the skin) in one of the following locations: arms, thigh or abdomen. During a subcutaneous injection, a needle is inserted under the skin, rather than into a vein.
Females
18+ years
Up to € 2.285, plus travel fees
Recruiting
Healthy Chinese participants
Healthy Chinese participants needed
The Pfizer Clinical Research Unit of Brussels will be conducting research studies in the near future with participants of Chinese descent.
Male or Female
18 - 55 years
Compensation for time and transportation costs upon completion of the study
Interested in participating?
Call 0800/99.256 (+32 2 556 70 02 from abroad) or click here to see if you may qualify for our research unit’s ongoing clinical trials